JNK inhibitor and ferroptosis modulator as possible therapeutic modalities in Alzheimer disease (AD)
JNK inhibitor and ferroptosis modulator as possible therapeutic modalities in Alzheimer disease (AD)
About this item
Full title
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Alzheimer disease (AD) is among the most prevalent neurodegenerative diseases globally, marked by cognitive and behavioral disruptions. Ferroptosis is a form of controlled cell death characterized by intracellular iron accumulation associated with lipid peroxide formation, which subsequently promotes AD initiation and progression. We hypothesized t...
Alternative Titles
Full title
JNK inhibitor and ferroptosis modulator as possible therapeutic modalities in Alzheimer disease (AD)
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_ed132d9a3bcb4a698ce2fd93b665c359
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ed132d9a3bcb4a698ce2fd93b665c359
Other Identifiers
ISSN
2045-2322
E-ISSN
2045-2322
DOI
10.1038/s41598-024-73596-1
